Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - bosentanum - compresse rivestite con film - bosentanum 125 mg ut bosentanum monohydricum 129.082 mg, maydis amylum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium 0.315 mg, povidonum k 90, glyceroli dibehenas, magnesii stearas, Überzug: hypromellosum, triacetinum, talcum, ethylcellulosum, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - primaria e secondaria di ipertensione polmonare; sclerosi sistemica attiva digitale ulzerationserkrankung - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - galantaminum - capsule - galantaminum 8 mg per galantamini hydrobromidum, zucchero sfere corrisp. sintetico 50.9-58.21 mg, ethylcellulosum, hypromellosum, diethylis phthalas, macrogolum 400, kapselhülle: gelatina, e-171, drucktinte: lacca, propylenglycolum, e 172 (nero), una piccola scatola. - da lieve a moderata demenza da malattia di alzheimer di tipo - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - galantaminum - capsule - galantaminum 16 mg per galantamini hydrobromidum, zucchero sfere corrisp. sintetico 101.8-116.43 mg, ethylcellulosum, hypromellosum, diethylis phthalas, macrogolum 400, kapselhülle: gelatina, e-171, e-172 (rosso), drucktinte: lacca, propylenglycolum, e 172 (nero), una piccola scatola. - da lieve a moderata demenza da malattia di alzheimer di tipo - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - galantaminum - capsule - galantaminum 24 mg di galantamini hydrobromidum, zucchero sfere corrisp. sintetico 152.7-174.63 mg, ethylcellulosum, hypromellosum, diethylis phthalas, macrogolum 400, kapselhülle: gelatina, e-171, e 172 (giallo) e 172 (rosso), drucktinte: lacca, propylenglycolum, e 172 (nero), una piccola scatola. - da lieve a moderata demenza da malattia di alzheimer di tipo - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - miglustatum - capsule - miglustatum 100 mg, carboxymethylamylum natricum a, povidonum k 30, magnesii stearas, kapselhülle: gelatina, e 171, drucktinte: e 172 (nigrum), lacca, pro capsula corresp. natrium 190 µg. - trattamento della malattia di gaucher di tipo 1, il trattamento neurologica progressiva manifestazioni pazienti adulti e pediatrici con niemann-pick, malattia di tipo c - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - paliperidonum - retardtabletten - paliperidonum 3 mg, polyethyleni oxidum, natrii chloridum corresp. natrium 11.8 mg, povidonum k 29-32, acidum stearicum, e 172 (rubrum), e 321, Überzug: hydroxyethylcellulosum, macrogolum 3350, cellulosi acetas, hypromellosum, lactosum monohydricum 13.2 mg, triacetinum, cera carnauba, e 171, drucktinte: hypromellosum, propylenglycolum, e 172 (nigrum), pro compresso obducto. - antipsicotico - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - paliperidonum - retardtabletten - paliperidonum 6 mg, polyethyleni oxidum, natrii chloridum corresp. natrium 11.8 mg, povidonum k 29-32, acidum stearicum, e 172 (rubrum), e 321, Überzug: hydroxyethylcellulosum, macrogolum 3350, cellulosi acetas, hypromellosum, macrogolum 400, cera carnauba, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: hypromellosum, propylenglycolum q.s., e 172 (nigrum), pro compresso obducto. - antipsicotico - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - paliperidonum - retardtabletten - paliperidonum 9 mg, polyethyleni oxidum, natrii chloridum corresp. natrium 11.8 mg, povidonum k 29-32, acidum stearicum, e 172 (rubrum), e 321, Überzug: hydroxyethylcellulosum, macrogolum 3350, cellulosi acetas, hypromellosum, macrogolum 400, cera carnauba, e 171, e 172 (rubrum), drucktinte: hypromellosum, propylenglycolum, e 172 (nigrum), pro compresso obducto. - antipsicotico - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - hydromorphonum - retardtabletten - hydromorphoni hydrochloridum 8 mg corresp. hydromorphonum 7.12 mg, macrogolum 200'000, povidonum k 29-32, magnesii stearas, e 321, macrogolum 2'000'000, natrii chloridum corresp. natrium 7.02 mg, hypromellosum, e 172 (nigrum), lactosum 0.012 mg, cellulosi acetas, macrogolum 3350, Überzug: lactosum monohydricum 4.36 mg, hypromellosum, e 171, e 172 (rubrum), triacetinum, macrogolum 400, drucktinte: e 172 (nigrum), hypromellosum, propylenglycolum, pro compresso obducto. - analgesico - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - hydromorphonum - retardtabletten - hydromorphoni hydrochloridum 16 mg corresp. hydromorphonum 14.24 mg, macrogolum 200'000, povidonum k 29-32, magnesii stearas, e 321, macrogolum 2'000'000, natrii chloridum corresp. natrium 15.21 mg, hypromellosum, e 172 (nigrum), lactosum 0.026 mg, cellulosi acetas, macrogolum 3350, Überzug: lactosum monohydricum 6.79 mg, hypromellosum, e 171, e 172 (flavum), triacetinum, macrogolum 400, drucktinte: e 172 (nigrum), hypromellosum, propylenglycolum, pro compresso obducto. - analgesico - synthetika